Download Sample
Add to CartMagnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market
By Product Type;
Needle-Based Biopsy Devices, Endoscopic Biopsy Devices, Core Needle Biopsy Devices, Vacuum-Assisted Biopsy Devices and Fine Needle Aspiration Biopsy DevicesBy Application;
Oncology, Cardiology, Neurology, Gastroenterology and OrthopedicsBy End User;
Hospitals, Diagnostic Laboratories, Outpatient Surgery Centers, Research Institutions and Radiology ClinicsBy Technology;
Electromagnetic Navigation, Ultrasound-Guided Biopsy Devices, CT-Guided Biopsy Devices, MR-Guided Biopsy Techniques and Optical Biopsy DevicesBy Distribution Channel;
Direct Sales, Distributors, E-Commerce Platforms, Hospitals & Healthcare Systems and Online MarketplacesBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031).MRI Compatible Biopsy Devices Market Overview
MRI Compatible Biopsy Devices Market (USD Million)
MRI Compatible Biopsy Devices Market was valued at USD 261.00 million in the year 2024. The size of this market is expected to increase to USD 477.12 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.0%.
Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market
*Market size in USD million
CAGR 9.0 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 9.0 % |
| Market Size (2024) | USD 261.00 Million |
| Market Size (2031) | USD 477.12 Million |
| Market Concentration | Medium |
| Report Pages | 303 |
Major Players
- Danaher Corporation
- Argon Medical Devices Inc
- Becton
- Dickinson & Company
- Sterylab S.R.L
- Scion Medical Technologies LLC
- Siemens AG
- Medtronic plc
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market
Fragmented - Highly competitive market without dominant players
MRI Compatible Biopsy Devices Market is expanding as over 60% of health systems adopt MRI-guided instruments for precise tissue sampling under real-time imaging. Enhanced collaboration between engineering teams and radiology clinicians is accelerating the delivery of safe, MRI-visible biopsy systems. Key strategies emphasize mechanical stability, imaging visibility, and patient comfort during sampling.
Advanced Materials and Feedback Technologies Increase Accuracy
More than 55% of biopsy devices now leverage technological innovations like polymer composites, MRI marker coils, and sensor-based targeting feedback. These tools improve needle placement accuracy and facilitate live adjustment mid-procedure. Continuous innovation in imaging-compatible actuator systems and software synchronization is enabling the expansion of devices across diverse biopsy applications.
Emphasis on Safety Compliance Shapes Product Design
Approximately 58% of new platforms meet stringent MRI environment standards, integrating thermal sensors, torque-resistant insulation, and non-ferrous components. This future outlook reflects commitment to patient and operator safety. The expansion of locking systems and needle shielding options further enhances safe use during prolonged imaging sessions.
Digital Integration and Device Analytics Raise Usability
Close to 62% of biopsy platforms now offer data-driven personalization, with digital procedural records, imaging overlays, and customizable alert systems. These tools support growth through smoother workflows and improved operator feedback. Real-time analytics allow review of targeting events, aiding continuous refinement of MRI-guided biopsy protocols.
Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market Key Takeaways
-
The MRI-Compatible Biopsy Devices Market is growing rapidly as MRI-guided biopsy procedures gain traction for their superior imaging accuracy, tissue differentiation, and ability to detect early-stage malignancies.
-
Rising cancer prevalence and the increasing adoption of minimally invasive diagnostic techniques are major drivers accelerating market demand for advanced MRI-safe biopsy systems.
-
Key product segments include biopsy needles, guns, and guidance accessories engineered with non-magnetic materials to prevent interference and ensure precise tissue sampling under MRI conditions.
-
Hospitals and diagnostic imaging centers dominate end-user adoption due to their advanced MRI suites and skilled radiologists capable of performing image-guided interventions.
-
North America and Europe lead global adoption, driven by robust healthcare infrastructure, while Asia-Pacific is emerging as a key growth region owing to rising investments in medical imaging facilities.
-
Challenges include high device costs, limited MRI-guided interventional availability in developing economies, and training requirements for specialized personnel.
-
Future opportunities focus on AI-assisted targeting systems, portable MRI-compatible tools, and improved material science innovations enhancing precision and workflow efficiency in biopsy procedures.
Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market Recent Developments
-
In May 2023, Argon Medical Devices launched the SuperCore Advantage Semi-Automatic Biopsy Instrument, expanding its soft tissue biopsy product portfolio and strengthening its position in the minimally invasive diagnostics market.
-
In May 2022, Terumo entered into a partnership with Argon Medical to broaden its reach by offering comprehensive medical solutions, including advanced tools for biopsies and deep vein thrombosis treatments.
Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market Segment Analysis
In this report, the Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market has been segmented by Product Type, Application, End User, Technology, Distribution Channel, and Geography.
Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market, Segmentation by Product Type
The market is segmented by Product Type, including Needle-Based Biopsy Devices, Endoscopic Biopsy Devices, Core Needle Biopsy Devices, Vacuum-Assisted Biopsy Devices, and Fine Needle Aspiration Biopsy Devices. Needle-based biopsy devices lead the market due to their widespread use in tissue sampling, while vacuum-assisted devices are gaining popularity due to their ability to retrieve larger tissue samples with greater precision.
-
Needle-Based Biopsy Devices
Needle-based biopsy devices are the most common type, used for obtaining tissue samples from patients with minimal discomfort. These devices are particularly effective in performing biopsies in oncology and neurology applications.
-
Endoscopic Biopsy Devices
Endoscopic biopsy devices allow for minimally invasive sampling, typically used in procedures where visualization of the biopsy site is necessary, such as in gastrointestinal and pulmonary diagnostics.
-
Core Needle Biopsy Devices
Core needle biopsy devices are used to obtain tissue samples from deep organs, offering higher accuracy and larger samples. These devices are commonly used in oncology for diagnosing solid tumors.
-
Vacuum-Assisted Biopsy Devices
Vacuum-assisted biopsy devices provide higher precision by utilizing suction to collect larger tissue samples. These devices are preferred in breast cancer diagnosis and other solid tumor applications.
-
Fine Needle Aspiration Biopsy Devices
Fine needle aspiration biopsy devices are used to collect small tissue samples, often used for diagnosing cancers in organs like the thyroid, lymph nodes, and pancreas.
Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market, Segmentation by Application
The market is segmented by Application, including Oncology, Cardiology, Neurology, Gastroenterology, and Orthopedics. Oncology holds the largest market share, driven by the increasing incidence of cancer and the need for precise diagnostic techniques for tumor detection and characterization. Neurology and cardiology also contribute significantly due to the high demand for MRI-compatible biopsy devices in diagnosing brain tumors and cardiac tissue analysis.
-
Oncology
Oncology is the largest application segment, as biopsy devices are critical for detecting and diagnosing various cancers, including breast, lung, and prostate cancer. MRI-compatible devices help in accurately targeting tumors for tissue sampling.
-
Cardiology
Cardiology applications involve using biopsy devices to sample cardiac tissue for diagnosing conditions like myocarditis, tumors, and other heart diseases. MRI guidance ensures precision when sampling from the heart.
-
Neurology
Neurology uses MRI-compatible biopsy devices for brain tumor sampling and diagnosing neurological conditions, such as multiple sclerosis and neurodegenerative diseases. MRI guidance helps in reaching deep brain structures with high precision.
-
Gastroenterology
Gastroenterology benefits from MRI-compatible biopsy devices in diagnosing liver diseases, gastrointestinal cancers, and other conditions where tissue samples are required for accurate diagnosis and treatment planning.
-
Orthopedics
Orthopedics involves using biopsy devices to diagnose bone cancers, infections, and other musculoskeletal disorders. MRI-compatible devices provide real-time imaging to guide accurate tissue sampling from bone or joint areas.
Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market, Segmentation by End-User
The End-User segmentation includes Hospitals, Diagnostic Laboratories, Outpatient Surgery Centers, Research Institutions, and Radiology Clinics. Hospitals are the primary end-users due to their advanced diagnostic and treatment capabilities, while diagnostic laboratories and radiology clinics also play a significant role in conducting biopsy procedures for various specialties.
-
Hospitals
Hospitals are the largest end-users of MRI-compatible biopsy devices, offering a wide range of diagnostic and therapeutic services. These devices are used for both inpatient and outpatient procedures, especially in oncology, neurology, and cardiology departments.
-
Diagnostic Laboratories
Diagnostic laboratories play a key role in the market, as they specialize in tissue sample analysis. These labs use MRI-compatible biopsy devices for accurate sampling and diagnosis of various diseases, including cancers and neurological disorders.
-
Outpatient Surgery Centers
Outpatient surgery centers are increasingly adopting MRI-compatible biopsy devices for minimally invasive procedures, allowing patients to undergo diagnostic tests without the need for overnight hospitalization.
-
Research Institutions
Research institutions use MRI-compatible biopsy devices for clinical trials and scientific research on disease mechanisms and new treatment options. These institutions rely on precise biopsy techniques for accurate data collection.
-
Radiology Clinics
Radiology clinics are significant end-users of MRI-guided biopsy devices, providing advanced imaging services and biopsy procedures for patients with various medical conditions, particularly in diagnostic imaging.
Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market, Segmentation by Technology
The market is segmented by Technology, including Electromagnetic Navigation, Ultrasound-Guided Biopsy Devices, CT-Guided Biopsy Devices, MR-Guided Biopsy Techniques, and Optical Biopsy Devices. MR-guided biopsy techniques are the leading technology due to their high precision in locating and sampling tissues with MRI guidance. Electromagnetic navigation and ultrasound-guided techniques are gaining traction for their effectiveness in certain diagnostic and therapeutic procedures.
-
Electromagnetic Navigation
Electromagnetic navigation uses magnetic fields to guide biopsy devices to the target tissue. This technology is useful in complex procedures requiring high precision, such as in cardiac and neurology biopsies.
-
Ultrasound-Guided Biopsy Devices
Ultrasound-guided biopsy devices combine real-time imaging with biopsy procedures, allowing clinicians to guide needles or probes into the affected area. This method is widely used for soft tissue sampling.
-
CT-Guided Biopsy Devices
CT-guided biopsy devices are used in cases where MRI or ultrasound is not feasible, providing detailed cross-sectional imaging to guide needle placement for accurate sampling of organs and tissues.
-
MR-Guided Biopsy Techniques
MR-guided biopsy techniques are the gold standard for biopsy procedures involving complex tissues. These techniques leverage the precision of MRI to identify target areas, offering minimal risk and high accuracy.
-
Optical Biopsy Devices
Optical biopsy devices use light-based technologies to provide real-time, high-resolution imaging of tissue. These devices are useful for early detection and accurate characterization of lesions and tumors.
Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market, Segmentation by Distribution Channel
The market is segmented by Distribution Channel, including Direct Sales, Distributors, E-Commerce Platforms, Hospitals & Healthcare Systems, and Online Marketplaces. Direct sales remain the largest channel, driven by hospital procurement and institutional purchases. E-commerce platforms and online marketplaces are gaining in popularity for their convenience and broad accessibility.
-
Direct Sales
Direct sales remain a dominant distribution channel for MRI-compatible biopsy devices, with manufacturers directly selling to hospitals and healthcare institutions for bulk procurement and specialized requirements.
-
Distributors
Distributors play a crucial role in the market by providing devices to various healthcare facilities and ensuring timely delivery of biopsy equipment, particularly in regions with established medical supply chains.
-
E-Commerce Platforms
E-commerce platforms are increasingly being used for purchasing MRI-compatible biopsy devices, offering convenience for clinics and hospitals to acquire devices directly from manufacturers or authorized suppliers online.
-
Hospitals & Healthcare Systems
Hospitals & healthcare systems are significant purchasers of MRI-compatible biopsy devices, typically through established procurement processes involving bulk orders and long-term contracts with manufacturers.
-
Online Marketplaces
Online marketplaces have gained traction in the distribution of medical devices, providing easy access for smaller clinics and individual practitioners to purchase MRI-compatible biopsy tools and equipment.
Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market, Segmentation by Geography
The Geography segmentation includes regions such as North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America leads the market due to advanced healthcare infrastructure and high demand for precision diagnostic tools. Europe follows closely, with strong demand for MR-guided biopsy techniques in oncology and neurology. The Asia Pacific region is expected to see significant growth, driven by healthcare expansion and increasing awareness of advanced diagnostic methods.
Regions and Countries Analyzed in this Report
North America
North America leads the MRI-compatible biopsy devices market due to advanced medical infrastructure, strong healthcare spending, and significant demand for precision diagnostic tools across hospitals and research institutions.
Europe
Europe follows closely, with high adoption of MRI-guided biopsy techniques, particularly in oncology and neurology. The market is supported by well-established healthcare systems and increasing demand for minimally invasive diagnostic technologies.
Asia Pacific
Asia Pacific is expected to experience rapid growth due to increasing healthcare investments, expanding medical infrastructure, and rising awareness of advanced biopsy techniques for accurate diagnosis and treatment.
Middle East & Africa
Middle East & Africa is gradually adopting MRI-compatible biopsy devices, driven by improvements in healthcare systems and investments in medical technologies aimed at enhancing diagnostic capabilities.
Latin America
Latin America is seeing steady growth, driven by increasing access to advanced medical devices and rising healthcare expenditures in countries such as Brazil, Mexico, and Argentina.
Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market Forces
This report provides an in depth analysis of various factors that impact the dynamics of MRI Compatible Biopsy Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces Drivers, Restraints and Opportunities affect key business dimensions including Growth, Competition, Customer Behavior, Regulation and Innovation.
| Market Forces ↓ Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
- Growing Incidence of Cancer
- Advancements in Imaging Technologies
- Rising Preference for Minimally Invasive Procedures
- Increasing Focus on Precision Medicine
- Expanding Geriatric Population-
The expanding geriatric population represents a significant demographic trend with profound implications for healthcare systems worldwide. As individuals age, they become more susceptible to various cancers and other diseases, including those affecting the gastrointestinal tract, liver, prostate, breast, and brain. Given the complexity and heterogeneity of geriatric patients' health profiles, accurate diagnosis and treatment planning are paramount. In this context, diagnostic procedures such as MRI-guided biopsies play a crucial role in detecting and characterizing suspicious lesions, guiding treatment decisions, and monitoring disease progression. The increasing prevalence of age-related conditions among the elderly population underscores the growing demand for advanced diagnostic tools capable of providing accurate and timely assessments of their health status.
Moreover, as the elderly population continues to expand globally, driven by factors such as increased life expectancy and declining birth rates, the demand for healthcare services, including diagnostic imaging procedures, is expected to rise correspondingly. MRI-guided biopsies offer distinct advantages in this demographic group, providing non-invasive and precise tissue sampling techniques that minimize patient discomfort and risk, particularly in frail or medically complex individuals. Healthcare providers are likely to increasingly rely on MRI-guided biopsies to address the diagnostic challenges associated with aging-related conditions, thereby driving market growth for MRI-compatible biopsy devices. In conclusion, the expanding geriatric population represents a significant driver for the growth of the MRI-compatible biopsy devices market, as the demand for accurate and minimally invasive diagnostic procedures continues to escalate in tandem with the aging demographic trend.
- High Cost of MRI-Compatible Biopsy Devices
- Technical Challenges and Complexity
- Limited Accessibility in Developing Regions
- Safety Concerns and Regulatory Compliance
- Alternative Diagnostic Modalities-
The availability of alternative diagnostic modalities presents both challenges and opportunities for the adoption of MRI-compatible biopsy devices. While MRI-guided biopsies offer distinct advantages in terms of superior soft tissue contrast and multiplanar imaging capabilities, other imaging modalities such as CT-guided biopsies and ultrasound-guided biopsies remain widely utilized, particularly in settings where MRI resources may be limited or inaccessible. CT-guided biopsies, for example, leverage the high-resolution imaging capabilities of computed tomography to precisely target lesions and obtain tissue samples, making them a preferred option in many clinical scenarios. Similarly, ultrasound-guided biopsies offer real-time visualization of anatomical structures and lesions, facilitating accurate needle placement and reducing procedure times. In settings where access to MRI technology is limited or where patients may have contraindications to MRI, such as those with pacemakers or metallic implants, alternative diagnostic modalities provide valuable alternatives for tissue sampling and diagnosis.
However, despite the availability of alternative diagnostic modalities, MRI-compatible biopsy devices continue to play a vital role in specific clinical contexts where MRI offers unique advantages, such as superior soft tissue contrast and multiplanar imaging capabilities. In cases where precise visualization of soft tissue structures or lesions is paramount, MRI-guided biopsies may offer distinct advantages over alternative modalities. Additionally, advancements in MRI technology, including the development of faster imaging sequences and higher field strengths, have improved the efficiency and accuracy of MRI-guided biopsy procedures, further enhancing their utility in clinical practice. As such, while alternative diagnostic modalities may compete with MRI-compatible biopsy devices in certain settings, the unique capabilities and evolving technological advancements of MRI continue to position it as a valuable tool for tissue sampling and diagnostic imaging in various medical specialties.
- Technological Advancements
- Emerging Markets
- Strategic Collaborations and Partnerships
- Focus on Patient-Centric Care
- Expansion of Indications-
The expansion of indications for MRI-guided biopsies beyond oncology into fields such as neurology and cardiology signifies a significant paradigm shift in medical imaging and diagnostic practices. Historically, MRI-guided biopsies have primarily been associated with oncology, where they play a critical role in the diagnosis and staging of various malignancies. However, advancements in MRI technology, coupled with growing expertise in interventional radiology, have enabled the application of MRI-guided biopsy techniques to a wider spectrum of medical specialties. In neurology, for example, MRI-guided biopsies offer a minimally invasive approach for obtaining tissue samples from deep-seated brain lesions, facilitating accurate diagnosis and treatment planning for conditions such as brain tumors, neurodegenerative diseases, and inflammatory disorders. Similarly, in cardiology, MRI-guided biopsies can provide valuable insights into myocardial tissue characteristics, helping to diagnose and manage conditions such as cardiomyopathies, myocarditis, and cardiac tumors.
As MRI technology continues to evolve and diversify, driven by advancements in imaging hardware, software, and imaging protocols, the potential applications for MRI-guided biopsy devices are expected to expand further. The versatility and precision offered by MRI-guided biopsies make them well-suited for a broad range of diagnostic and interventional procedures across various medical specialties. Furthermore, the integration of advanced imaging techniques, such as functional MRI and spectroscopy, with MRI-guided biopsy procedures holds promise for enhancing diagnostic accuracy and therapeutic outcomes in diverse clinical scenarios. With ongoing research and development efforts focused on optimizing MRI-guided biopsy techniques and expanding their utility beyond oncology, the market for MRI-compatible biopsy devices is poised for significant growth as these technologies become increasingly integrated into routine clinical practice across multiple medical disciplines.
Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market Competitive Landscape Analysis
Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market highlights a competitive space where established players control nearly 60% of the share through advanced strategies and robust partnerships. Market leaders strengthen positioning via collaboration and targeted merger initiatives, while new entrants emphasize product innovation. This balance supports sustainable growth across diagnostic and interventional applications in healthcare systems.
Market Structure and Concentration
The sector demonstrates moderate concentration, with around 55% commanded by top-tier companies while regional manufacturers contribute to competition. Integrated production and hospital-driven expansion define the structure, supported by specialized strategies from mid-sized firms. This alignment ensures competitive balance and reinforces consistent growth across biopsy technologies tailored for MRI compatibility.
Brand and Channel Strategies
Brands achieve nearly 65% coverage through strategic hospital networks, distributors, and direct supply agreements. Strong partnerships with healthcare institutions and research organizations drive visibility. Differentiation is achieved through service quality, clinical support, and precision-driven strategies, enabling both established players and emerging firms to sustain growth while advancing long-term market expansion.
Innovation Drivers and Technological Advancements
More than 70% of competitive momentum stems from technological advancements and device-level innovation. Companies invest in R&D and automation, emphasizing imaging precision and minimally invasive solutions. Strategic collaboration with hospitals and academic centers supports progressive strategies that ensure sustainable growth, reinforcing leadership in MRI-compatible biopsy device development.
Regional Momentum and Expansion
Asia-Pacific represents nearly 40% share, supported by healthcare infrastructure expansion and cost-effective solutions. North America emphasizes technological advancements and innovation-focused strategies, while Europe highlights institutional partnerships and clinical expertise. Collectively, regional momentum secures balanced growth and sustains competitiveness in advanced diagnostic and interventional procedures.
Future Outlook
The future outlook emphasizes adoption of precision-based innovation, with nearly 65% of companies expected to reinforce strategies through digital integration and automation. Rising merger activities and cross-sector partnerships will drive market transformation. Ongoing expansion and rapid technological advancements are projected to secure sustainable growth in MRI-compatible biopsy devices.
Key players inMagnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market include,
- Danaher Corporation
- Argon Medical Devices
- Becton, Dickinson and Company
- Siemens
- Cook Group
- Medtronic
- Sterylab
- Scion Medical Technologies
- Inrad
- Devicor Medical Products
- Hologic
- Olympus Corporation
- FUJIFILM
- Boston Scientific
- Stryker Corporation
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Technology
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market Forces
- Drivers, Restraints and Opportunities
- Drivers
- Growing Incidence of Cancer
- Advancements in Imaging Technologies
- Rising Preference for Minimally Invasive Procedures
- Increasing Focus on Precision Medicine
- Expanding Geriatric Population
- Restraints
- High Cost of MRI-Compatible Biopsy Devices
- Technical Challenges and Complexity
- Limited Accessibility in Developing Regions
- Safety Concerns and Regulatory Compliance
- Alternative Diagnostic Modalities
- Opportunities
- Technological Advancements
- Emerging Markets
- Strategic Collaborations and Partnerships
- Focus on Patient-Centric Care
- Expansion of Indications
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market, By Product Type, 2021 - 2031 (USD Million)
- Needlebased Biopsy Devices
- Endoscopic Biopsy Devices
- Core Needle Biopsy Devices
- Vacuum assisted Biopsy Devices
- Fine needle Aspiration Biopsy Devices
- Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market, By Application, 2021 - 2031 (USD Million)
- Oncology
- Cardiology
- Neurology
- Gastroenterology
- Orthopedics
- Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Diagnostic Laboratories
- Outpatient Surgery Centers
- Research-institutions
- Radiology Clinics
- Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market, By Technology, 2021 - 2031 (USD Million)
- Electromagnetic Navigation
- Ultrasound guided Biopsy Devices
- CT guided Biopsy Devices
- MR guided Biopsy Techniques
- Optical Biopsy Devices
- Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market, By Distribution Channel, 2021 - 2031 (USD Million)
- Direct Sales
- Distributors
- E Commerce Platforms
- Hospitals and Healthcare Systems
- Online Marketplaces
- Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Magnetic Resonance Imaging (MRI) Compatible Biopsy Devices Market, By Product Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Danaher Corporation
- Argon Medical Devices
- Becton, Dickinson and Company
- Siemens
- Cook Group
- Medtronic
- Sterylab
- Scion Medical Technologies
- Inrad
- Devicor Medical Products
- Hologic
- Olympus Corporation
- FUJIFILM
- Boston Scientific
- Stryker Corporation
- Company Profiles
- Analyst Views
- Future Outlook of the Market